Companies
ICAR
- Country
- India
Research
Coverage
| CN | EU | IN | US | |
|---|---|---|---|---|
| crop-biotech | ✓ | ✓ | ✓ | ✓ |
Regulatorsusda-aphisepaefsa
Verifiable facts
| Fact | Value | Source |
|---|---|---|
| Funding | INR 397.72 billion establishment expenses, INR 7.15 billion research and operational expenses (FY 2024-25) | icar.gov.in |
| Revenue | INR 1.098 billion from sales/service (FY 2024-25) | icar.gov.in |
| Headcount | Approximately 19,200 employees | icar.gov.in |
| Production site | ICAR manages 101 institutes and an extensive network of research centers across India | icar.org.in · frontiersin.org |
| Certification | ICAR manages intellectual property (IP) protection, including patents, plant variety rights, trademarks, and copyrights | sansad.in · icar.org.in |
| Regulatory approval | ICAR works with the Genetic Engineering Appraisal Committee (GEAC) for regulatory approvals of genetically modified crops and genome-edited varieties | pmc.ncbi.nlm.nih.gov · sansad.in |
Independent sources: frontiersin.org · pmc.ncbi.nlm.nih.gov · sansad.in
Technologies
| Name | Cluster | Risk | |
|---|---|---|---|
| Allelopathic crops | crop-biotech | Medium | → |
Compiled by BIOECON from primary sources.
Compliance
Bioecon is an information intermediary; it is not a regulator, a certification body, or a legal advisor. When working with public-sector customers (procurement under 44-FZ / 223-FZ), Bioecon acts solely as an independent analytical platform, with no remuneration from suppliers.